121 related articles for article (PubMed ID: 16631271)
1. Characterization of insulin protection properties of complexation hydrogels in gastric and intestinal enzyme fluids.
Yamagata T; Morishita M; Kavimandan NJ; Nakamura K; Fukuoka Y; Takayama K; Peppas NA
J Control Release; 2006 May; 112(3):343-9. PubMed ID: 16631271
[TBL] [Abstract][Full Text] [Related]
2. Combination Strategy with Complexation Hydrogels and Cell-Penetrating Peptides for Oral Delivery of Insulin.
Fukuoka Y; Khafagy ES; Goto T; Kamei N; Takayama K; Peppas NA; Takeda-Morishita M
Biol Pharm Bull; 2018; 41(5):811-814. PubMed ID: 29709919
[TBL] [Abstract][Full Text] [Related]
3. In vitro release behavior and stability of insulin in complexation hydrogels as oral drug delivery carriers.
Kim B; Peppas NA
Int J Pharm; 2003 Nov; 266(1-2):29-37. PubMed ID: 14559391
[TBL] [Abstract][Full Text] [Related]
4. The effect of complexation hydrogels on insulin transport in intestinal epithelial cell models.
Wood KM; Stone GM; Peppas NA
Acta Biomater; 2010 Jan; 6(1):48-56. PubMed ID: 19481619
[TBL] [Abstract][Full Text] [Related]
5. Wheat germ agglutinin functionalized complexation hydrogels for oral insulin delivery.
Wood KM; Stone GM; Peppas NA
Biomacromolecules; 2008 Apr; 9(4):1293-8. PubMed ID: 18330990
[TBL] [Abstract][Full Text] [Related]
6. Novel complexation hydrogels for oral peptide delivery: in vitro evaluation of their cytocompatibility and insulin-transport enhancing effects using Caco-2 cell monolayers.
Ichikawa H; Peppas NA
J Biomed Mater Res A; 2003 Nov; 67(2):609-17. PubMed ID: 14566804
[TBL] [Abstract][Full Text] [Related]
7. Complexation hydrogels for intestinal delivery of interferon beta and calcitonin.
Kamei N; Morishita M; Chiba H; Kavimandan NJ; Peppas NA; Takayama K
J Control Release; 2009 Mar; 134(2):98-102. PubMed ID: 19095021
[TBL] [Abstract][Full Text] [Related]
8. Complexation hydrogels for oral insulin delivery: effects of polymer dosing on in vivo efficacy.
Tuesca A; Nakamura K; Morishita M; Joseph J; Peppas N; Lowman A
J Pharm Sci; 2008 Jul; 97(7):2607-18. PubMed ID: 17876768
[TBL] [Abstract][Full Text] [Related]
9. New terpolymers as hydrogels for oral protein delivery application.
Mahkam M
J Drug Target; 2009 Jan; 17(1):29-35. PubMed ID: 19016070
[TBL] [Abstract][Full Text] [Related]
10. Mucosal insulin delivery systems based on complexation polymer hydrogels: effect of particle size on insulin enteral absorption.
Morishita M; Goto T; Peppas NA; Joseph JI; Torjman MC; Munsick C; Nakamura K; Yamagata T; Takayama K; Lowman AM
J Control Release; 2004 May; 97(1):115-24. PubMed ID: 15147809
[TBL] [Abstract][Full Text] [Related]
11. PEGylated insulin loaded complexation hydrogels for protected oral delivery.
Coolich MK; Lanier OL; Cisneros E; Peppas NA
J Control Release; 2023 Dec; 364():216-226. PubMed ID: 37890591
[TBL] [Abstract][Full Text] [Related]
12. [Application of pH-responsive polymers to oral dosage forms for insulin].
Morishita M; Takayama K
Nihon Rinsho; 2001 Nov; 59(11):2255-60. PubMed ID: 11712416
[TBL] [Abstract][Full Text] [Related]
13. Novel oral insulin delivery systems based on complexation polymer hydrogels: single and multiple administration studies in type 1 and 2 diabetic rats.
Morishita M; Goto T; Nakamura K; Lowman AM; Takayama K; Peppas NA
J Control Release; 2006 Feb; 110(3):587-94. PubMed ID: 16325951
[TBL] [Abstract][Full Text] [Related]
14. Gastrointestinal transit and mucoadhesive characteristics of complexation hydrogels in rats.
Goto T; Morishita M; Kavimandan NJ; Takayama K; Peppas NA
J Pharm Sci; 2006 Feb; 95(2):462-9. PubMed ID: 16381013
[TBL] [Abstract][Full Text] [Related]
15. Poly(ester amide) blend microspheres for oral insulin delivery.
He P; Liu H; Tang Z; Deng M; Yang Y; Pang X; Chen X
Int J Pharm; 2013 Oct; 455(1-2):259-66. PubMed ID: 23876502
[TBL] [Abstract][Full Text] [Related]
16. Complexation hydrogels for oral protein delivery: an in vitro assessment of the insulin transport-enhancing effects following dissolution in simulated digestive fluids.
Perakslis E; Tuesca A; Lowman A
J Biomater Sci Polym Ed; 2007; 18(12):1475-90. PubMed ID: 17988515
[TBL] [Abstract][Full Text] [Related]
17. Oral insulin delivery using P(MAA-g-EG) hydrogels: effects of network morphology on insulin delivery characteristics.
Nakamura K; Murray RJ; Joseph JI; Peppas NA; Morishita M; Lowman AM
J Control Release; 2004 Mar; 95(3):589-99. PubMed ID: 15023469
[TBL] [Abstract][Full Text] [Related]
18. Development of PEGDMA: MAA based hydrogel microparticles for oral insulin delivery.
Kumar A; Lahiri SS; Singh H
Int J Pharm; 2006 Oct; 323(1-2):117-24. PubMed ID: 16828246
[TBL] [Abstract][Full Text] [Related]
19. Complexation graft copolymer networks: swelling properties, calcium binding and proteolytic enzyme inhibition.
Madsen F; Peppas NA
Biomaterials; 1999 Sep; 20(18):1701-8. PubMed ID: 10503971
[TBL] [Abstract][Full Text] [Related]
20. Effect of poly (ethylene glycol) molecular weight and microparticle size on oral insulin delivery from P(MAA-g-EG) microparticles.
López JE; Peppas NA
Drug Dev Ind Pharm; 2004 May; 30(5):497-504. PubMed ID: 15244085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
